Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

Price to free cash flow ratio

Percentile
P14
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-7.94-250.3%
2024-2.27-8.6%
2023-2.09+83.0%
2022-12.30+24.1%
2021-16.20-110.0%
2020161.77+807.4%
201917.83-73.1%
201866.19+272.0%
201717.79+9.8%
201616.21-